OncoTargets and Therapy (Sep 2021)
Long Noncoding RNA DLEU1 Aggravates Glioma Progression via the miR-421/MEF2D Axis [Retraction]
Abstract
Feng L, He M, Rao M, Diao J, Zhu Y. Onco Targets Ther. 2019;12:5405–5414. The Editor and Publisher of OncoTargets and Therapy wish to retract the published article. The authors initially raised concerns that two of the glioma cell lines (LN229 and A172) reported in the study had been contaminated with HeLa cells. The authors advised that they were unable to provide the original raw data for their study and thus were unable to verify its findings. The authors also advised the study did not have approval from the China-Japan Union Hospital of Jilin University ethical committee prior to commencement. This is despite a statement within the article stating that approval had been given. Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”. This retraction relates to this paper
